Ketamine for Anxiety
A careful summary of what current research does — and does not — support about ketamine for anxiety disorders, with an emphasis on established care.
Condition overview
Anxiety disorders include generalized anxiety disorder, social anxiety, panic disorder, specific phobias, and others. They are common, frequently treatable, and often respond well to structured psychological care, sometimes combined with medication.
Anxiety also commonly co-occurs with depression. Some of the ketamine literature in anxiety actually reflects patients with anxious depression, which is important context when interpreting results.
Current standard treatments
- Cognitive behavioral therapy (CBT) and exposure-based therapies
- SSRIs and SNRIs as first-line medications
- Limited, cautious use of benzodiazepines, typically short-term
- Buspirone, hydroxyzine, and select adjuncts in specific cases
- Lifestyle support — sleep, physical activity, reduced stimulant use
How ketamine might act on anxiety
Proposed mechanisms include rapid modulation of glutamate signaling, downstream effects on synaptic plasticity, and reduction of fear-related reactivity in limbic circuits. These are plausible but not yet well-established as a basis for routine clinical use in anxiety.
Where ketamine may fit
Most rigorous studies of ketamine in anxiety focus on patients who also have depression. Effect sizes, durability, and ideal protocols remain active questions. Some clinicians consider ketamine when conventional approaches have not provided sufficient relief — under thorough screening, careful preparation, and proper supervision.
Risks and limitations
Ketamine carries the same risk profile across conditions: transient dissociation, elevated blood pressure, nausea, emotional intensity, and — with unsupervised or frequent use — meaningful potential for harm. For some anxious patients, the dissociative experience itself can be distressing. See safety & eligibility.
Who is not a candidate
- Uncontrolled cardiovascular disease
- Active psychosis or untreated bipolar mania
- Active substance use disorders
- Pregnancy
- People for whom dissociation is likely to be re-traumatizing without strong preparation and integration
Frequently asked questions
Is ketamine approved for anxiety?+
No. Ketamine is not FDA-approved for anxiety disorders. The evidence base is earlier-stage than for depression, and ketamine is not considered first-line care for anxiety.
What does the evidence suggest?+
Some small studies show short-term reductions in anxiety symptoms, particularly when anxiety co-occurs with depression. Larger, well-controlled trials are still needed before strong conclusions can be drawn.
What is first-line care for anxiety?+
CBT and exposure-based therapies, along with SSRIs and SNRIs, are well-supported and typically tried first. Benzodiazepines are generally avoided for long-term use because of tolerance and dependence.
Who should not consider ketamine for anxiety?+
People with uncontrolled cardiovascular disease, active psychosis, certain substance use disorders, pregnancy, or other contraindications. A clinician should perform a full medical and psychiatric screening.
Which anxiety disorders have been studied?+
Most ketamine research in anxiety focuses on generalized anxiety disorder, social anxiety disorder, and anxious depression. Evidence for panic disorder and specific phobias is even more limited.
Could ketamine make anxiety worse?+
Yes, in some people. The dissociative effects of ketamine can feel disorienting or frightening, especially without good preparation and a calm setting. Some patients experience increased anxiety during or after sessions.
How is dosing different from depression?+
Protocols are not well standardized for anxiety. Many clinicians use subanesthetic dosing similar to depression protocols, but optimal frequency and duration for anxiety specifically have not been established by large trials.
Can ketamine replace therapy for anxiety?+
No. Anxiety disorders typically respond well to structured psychological treatment, especially exposure-based therapy. Ketamine, when considered at all, is generally an adjunct, not a replacement.
Does it help anticipatory anxiety or performance anxiety?+
There is no good evidence supporting ketamine for situational anxieties like performance or test anxiety. These are better addressed with skills-based therapy and, when appropriate, targeted medication.
Is the calming effect durable?+
Any short-term symptom reduction from a single ketamine session typically fades within days to a couple of weeks. Durability without repeated dosing and broader care is generally poor.
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.